Product Name: Human BST2 / CD317 Antibody (SBI Biotech patent anti-BST2, Research Use)
Catalog Number: NBR-0864
Target Name: BST2 / CD317
Trade Name: SBI Biotech patent anti-BST2
Antibody Drug Description: The drug is a recombinant fully human anti-BST2 monoclonal antibody, being developed by SBI Biotech. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name:  BST2
Synonyms: CD317; tetherin
Target Description: IFN-induced antiviral host restriction factor which efficiently blocks the release of diverse mammalian enveloped viruses by directly tethering nascent virions to the membranes of infected cells. Acts as a direct physical tether, holding virions to the cell membrane and linking virions to each other.
Ensembl:  ENSG00000130303
Uniprot:  Q10589